Researchers repurpose drug to deny drug-resistant fungus of iron, an element crucial to its survival
How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers.
To treat Candida albicans, a common yeast that can cause illness in those with weakened immune systems, researchers limited the fungus’ access to iron, an element crucial to the organism’s survival.
“In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat diseases is a promising strategy.”Mira Edgerton, research professor in the Department of Oral Biology at the UB School of Dental Medicine
They did so by using deferasirox, a medication used to treat blood disorders. Tested in mice, the results were promising: investigators decreased iron levels in saliva by four times, which altered the expression of more than 100 genes by the fungus, diminished its ability to infect oral mucosal tissue and caused a two-fold reduction in the organism’s survival rate.
“In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat diseases is a promising strategy,” says Mira Edgerton, DDS, PhD, co-lead investigator of the study and research professor in the Department of Oral Biology at the UB School of Dental Medicine.
Edgerton, along with Sumant Puri, PhD, co-lead investigator and assistant professor in the Kornberg School of Dentistry at Temple University, published the study in March in Antimicrobial Agents and Chemotherapy.
Currently, only three major classes of clinical antifungal drugs exist. However, fungal drug resistance has steadily increased and no new classes of antifungals have emerged in decades, says Edgerton.
Candida albicans, a fungus among the group building resistance, is the agent behind a number of infections. They include oral thrush, a yeast infection in the mouth identified by a white film that coats the tongue and throat, causing painful swallowing; and denture-related stomatitis, a fungal infection that affects nearly two-thirds of U.S. denture wearers that causes inflammation, redness and swelling in the mouth.
The yeast is also the fourth leading cause of hospital-acquired bloodstream infections, which often have high mortality rates, says Edgerton.
Candida albicans is the most abundant fungus in the oral microbiome and relies heavily on saliva as a source for essential elements. Iron, the second most abundant metal in saliva, is a critical nutrient used by the fungus in several cellular processes, including energy production and DNA repair.
In mice, the group added deferasirox to drinking water to lower iron levels in saliva and reduce the availability of iron needed to sustain an infection.
The investigators found that Candida albicans in the mice who received the treatment were less likely to survive attacks by the immune system, subsisting at a 12 percent survival rate compared to a 25 percent survival rate in mice who did not receive the treatment.
The therapy also altered the expression of 106 genes by the fungus, a quarter of which were involved in the regulation of iron metabolism, directly regulated by iron or had iron-related functions. The study is the first report of iron starvation affecting gene expression of Candida albicans in real time during live infection, says Puri.
Other research has shown that treatment with deferasirox does not result in iron deficiency in adults with normal iron levels, forming the potential for preventative treatment for those who are also vulnerable to mucosal infections, says Puri.
The Latest on: Drug-resistant fungal infections
via Google News
The Latest on: Drug-resistant fungal infections
- As More Bacteria Grow Resistant to Antibiotics, Scientists are Fighting Backon January 21, 2021 at 9:04 am
Scottish bacteriologist Alexander Fleming's discovery of penicillin, the world's first antibiotic, saved countless lives. But even as the bacteria ...
- Becker's Clinical Leadership & Infection Control E-Newsletteron January 20, 2021 at 1:46 pm
To sign up for Becker's Clinical Leadership & Infection Control E-Newsletter or any of our other E-Newsletters, click here. If you are experiencing difficulty receiving our newsletters, you may need ...
- New antifungal compound from ant farmson January 20, 2021 at 12:44 pm
It was also effective in fighting a Candida albicans infection in mice, comparable to azole-containing antifungal treatments that are used clinically, making it a potential drug candidate.
- Study shows that single water molecule may cause antibiotic resistanceon January 20, 2021 at 7:22 am
Each year in the U.S., millions of people suffer from antibiotic-resistant infections ... was not present in the ribosomes from the drug-resistant bugs. In the ribosomes from the drug-resistant ...
- Carbon-based nanomaterials as potential COVID-19 treatmentson January 18, 2021 at 4:00 pm
viral or fungal infection. The team says that CBNs such as fullerene, carbon dots, graphene, and their derivatives could serve as effective alternatives to currently proposed therapies that have ...
- The microbiota in pneumonia: From protection to predispositionon January 15, 2021 at 6:46 pm
However, antimicrobial therapy and critical care procedures perturb the microbiota, thus compromising its function and predisposing to lung infections (pneumonia). Interindividual variations and ...
- Amid faulty disinfection, coronavirus patients battled deadly, drug-resistant fungus: CDCon January 12, 2021 at 6:53 am
The CDC says this yeast can cause serious infections and death ... raising the risk of further fungal spread; they wore gear like gowns and gloves throughout entire shifts, and didn’t ...
- In vitro Susceptibility Testing in Aspergillus Species: An Updateon January 10, 2021 at 4:00 pm
delay of early diagnosis and lack of efficient antifungal therapy. Another factor might be infection with drug-resistant fungal pathogens.
- Drug-resistant infections: If you can’t beat ‘em, starve ‘em, scientists findon January 7, 2021 at 4:00 pm
BUFFALO, N.Y. — How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers. To ...
- Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosison January 6, 2021 at 4:01 pm
Mucormycosis is a fungal infection with an often fatal prognosis (1 ... coupled with an inherent tendency for these fungi to be drug resistant (14). Only three antifungal drugs are currently approved ...
via Bing News